​

DarioHealth (DRIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DRIO Stock Forecast

DarioHealth (DRIO) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $16.00, with a high of $16.00 and a low of $16.00. This represents a 90.48% increase from the last price of $8.40.

- $4 $8 $12 $16 $20 High: $16 Avg: $16 Low: $16 Last Closed Price: $8.4

DRIO Stock Rating

DarioHealth stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

DRIO Price Target Upside V Benchmarks

TypeNameUpside
StockDarioHealth90.48%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks29.14%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$16.00
Last Closing Price$8.40$8.40$8.40
Upside/Downside--90.48%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-41--5
Mar, 26-31--4
Feb, 26-31--4
Jan, 26-31--4
Dec, 25-31--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2025Stifel Nicolaus$16.00$10.6150.80%90.48%
Nov 16, 2022Industrial Alliance Securities$7.50$5.1844.79%-10.71%
Aug 18, 2022Cowen & Co.$14.00$5.49155.01%66.67%
May 16, 2022Cowen & Co.$18.00$6.33184.36%114.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 14, 2025Cowen & Co.HoldHoldhold
May 19, 2025Litchfield HillsBuyinitialise
Jun 14, 2024Cowen & Co.BuyBuyhold
Nov 16, 2022Alliance Global PartnersBuyBuyhold
Aug 18, 2022Aegis CapitalBuyBuyhold
Aug 18, 2022Cowen & Co.OutperformOutperformhold
May 16, 2022Aegis CapitalBuyBuyhold
May 16, 2022Cowen & Co.OutperformOutperformhold
May 13, 2022Alliance Global PartnersBuyupgrade

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-4.63$-2.63$-1.93$0.61$10.12--
Avg Forecast$-4.72$-2.93$-1.54$-1.12$-1.01$-0.86$-0.63
High Forecast$-4.57$-2.83$-1.46$-1.07$-0.96$-0.60$-0.60
Low Forecast$-4.89$-3.00$-1.64$-1.20$-1.08$-1.11$-0.67
Surprise %-1.91%-10.24%25.32%-154.46%-1101.98%--

Revenue Forecast

$15M $22M $29M $36M $43M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$20.51M$27.66M$20.35M$27.04M$22.36M--
Avg Forecast$20.61M$27.59M$20.50M$26.81M$35.63M$41.35M$47.14M
High Forecast$21.19M$28.09M$21.54M$28.16M$37.43M$43.44M$49.52M
Low Forecast$20.12M$26.84M$19.73M$25.80M$34.29M$39.79M$45.36M
Surprise %-0.49%0.23%-0.75%0.86%-37.25%--

Net Income Forecast

$-150M $-100M $-50M $0 $50M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-76.76M$-62.19M$-59.43M$-42.75M$61.73M--
Avg Forecast$-133.88M$-83.24M$-44.05M$-32.30M$-28.99M$-24.26M$-18.02M
High Forecast$-129.74M$-80.31M$-41.55M$-30.31M$-27.34M$-16.90M$-17.00M
Low Forecast$-138.74M$-85.20M$-46.56M$-33.96M$-30.64M$-31.61M$-19.05M
Surprise %-42.66%-25.29%34.89%32.35%-312.96%--

DRIO Forecast FAQ

Is DarioHealth stock a buy?

DarioHealth stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DarioHealth is a favorable investment for most analysts.

What is DarioHealth's price target?

DarioHealth's price target, set by 8 Wall Street analysts, averages $16 over the next 12 months. The price target range spans from $16 at the low end to $16 at the high end, suggesting a potential 90.48% change from the previous closing price of $8.4.

How does DarioHealth stock forecast compare to its benchmarks?

DarioHealth's stock forecast shows a 90.48% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (29.14%).

What is the breakdown of analyst ratings for DarioHealth over the past three months?

  • April 2026: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is DarioHealth’s EPS forecast?

DarioHealth's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.86, marking a -108.50% decrease from the reported $10.12 in 2025. Estimates for the following years are.

What is DarioHealth’s revenue forecast?

DarioHealth's average annual revenue forecast for its fiscal year ending in December 2026 is $41.35M, reflecting a 84.94% increase from the reported $22.36M in 2025. The forecast for.

What is DarioHealth’s net income forecast?

DarioHealth's net income forecast for the fiscal year ending in December 2026 stands at $-24.258M, representing a -139.29% decrease from the reported $61.74M in 2025. Projections indicate .